Clinical Trials Browser

Not yet recruiting × Cholangiocarcinoma × pemigatinib × Clear all

NCT06530823 2024-07-31

Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma